Literature DB >> 23648111

Zinc-induced modulation of SRSF6 activity alters Bim splicing to promote generation of the most potent apoptotic isoform BimS.

Hirokazu Hara1, Tatsuya Takeda, Nozomi Yamamoto, Keisuke Furuya, Kazuya Hirose, Tetsuro Kamiya, Tetsuo Adachi.   

Abstract

Bim is a member of the pro-apoptotic BH3-only Bcl-2 family of proteins. Bim gene undergoes alternative splicing to produce three predominant splicing variants (BimEL, BimL and BimS). The smallest variant BimS is the most potent inducer of apoptosis. Zinc (Zn(2+)) has been reported to stimulate apoptosis in various cell types. In this study, we examined whether Zn(2+) affects the expression of Bim in human neuroblastoma SH-SY5Y cells. Zn(2+) triggered alterations in Bim splicing and induced preferential generation of BimS, but not BimEL and BimL, in a dose- and time-dependent manner. Other metals (cadmium, cobalt and copper) and stresses (oxidative, endoplasmic reticulum and genotoxic stresses) had little or no effect on the expression of BimS. To address the mechanism of Zn(2+)-induced preferential generation of BimS, which lacks exon 4, we developed a Bim mini-gene construct. Deletion analysis using the Bim mini-gene revealed that predicted binding sites of the SR protein SRSF6, also known as SRp55, are located in the intronic region adjacent to exon 4. We also found that mutations in the predicted SRSF6-binding sites abolished generation of BimS mRNA from the mutated Bim mini-gene. In addition, a UV cross-linking assay followed by Western blotting showed that SRSF6 directly bound to the predicted binding site and Zn(2+) suppressed this binding. Moreover, Zn(2+) stimulated SRSF6 hyper-phosphorylation. TG003, a cdc2-like kinase inhibitor, partially prevented Zn(2+)-induced generation of BimS and SRSF6 hyper-phosphorylation. Taken together, our findings suggest that Zn(2+) inhibits the activity of SRSF6 and promotes elimination of exon 4, leading to preferential generation of BimS.
© 2013 FEBS.

Entities:  

Keywords:  Bim; SRSF6; Zinc; apoptosis; splicing

Mesh:

Substances:

Year:  2013        PMID: 23648111     DOI: 10.1111/febs.12318

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  12 in total

Review 1.  MECHANISMS IN ENDOCRINOLOGY: Alternative splicing: the new frontier in diabetes research.

Authors:  Jonàs Juan-Mateu; Olatz Villate; Décio L Eizirik
Journal:  Eur J Endocrinol       Date:  2015-12-01       Impact factor: 6.664

Review 2.  The RNAissance family: SR proteins as multifaceted regulators of gene expression.

Authors:  Jonathan M Howard; Jeremy R Sanford
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-08-22       Impact factor: 9.957

Review 3.  Role of precursor mRNA splicing in nutrient-induced alterations in gene expression and metabolism.

Authors:  Suhana Ravi; Rudolf J Schilder; Scot R Kimball
Journal:  J Nutr       Date:  2015-03-11       Impact factor: 4.798

Review 4.  Regulation of Bim in Health and Disease.

Authors:  Ronit Vogt Sionov; Spiros A Vlahopoulos; Zvi Granot
Journal:  Oncotarget       Date:  2015-09-15

5.  SRSF6 Regulates the Alternative Splicing of the Apoptotic Fas Gene by Targeting a Novel RNA Sequence.

Authors:  Namjeong Choi; Ha Na Jang; Jagyeong Oh; Jiyeon Ha; Hyungbin Park; Xuexiu Zheng; Sunjae Lee; Haihong Shen
Journal:  Cancers (Basel)       Date:  2022-04-14       Impact factor: 6.575

6.  Regulatory mechanisms of incomplete huntingtin mRNA splicing.

Authors:  Andreas Neueder; Anaelle A Dumas; Agnesska C Benjamin; Gillian P Bates
Journal:  Nat Commun       Date:  2018-09-27       Impact factor: 14.919

7.  Intron retention in the 5'UTR of the novel ZIF2 transporter enhances translation to promote zinc tolerance in arabidopsis.

Authors:  Estelle Remy; Tânia R Cabrito; Rita A Batista; Mohamed A M Hussein; Miguel C Teixeira; Alekos Athanasiadis; Isabel Sá-Correia; Paula Duque
Journal:  PLoS Genet       Date:  2014-05-15       Impact factor: 5.917

8.  PGE₂ promotes apoptosis induced by cytokine deprivation through EP3 receptor and induces Bim in mouse mast cells.

Authors:  Martina Kovarova; Beverly H Koller
Journal:  PLoS One       Date:  2014-07-23       Impact factor: 3.240

Review 9.  The Role of Alternative Splicing in the Control of Immune Homeostasis and Cellular Differentiation.

Authors:  Mehmet Yabas; Hannah Elliott; Gerard F Hoyne
Journal:  Int J Mol Sci       Date:  2015-12-22       Impact factor: 5.923

10.  Overcoming imatinib resistance conferred by the BIM deletion polymorphism in chronic myeloid leukemia with splice-switching antisense oligonucleotides.

Authors:  Jun Liu; Malini Bhadra; Joanna Rajeswary Sinnakannu; Wan Lin Yue; Cheryl Weiqi Tan; Frank Rigo; S Tiong Ong; Xavier Roca
Journal:  Oncotarget       Date:  2017-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.